Welcome
Support Centre
19 November 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
40kD pegylated interferon alpha 2a plus ribavirin compared to 40 kD pegylated interferon alpha 2a plus ribavirin and mycophenolate in the management of patients with refractory chronic HCV infection
ISRCTN ISRCTN52566041
ClinicalTrials.gov identifier
Public title 40kD pegylated interferon alpha 2a plus ribavirin compared to 40 kD pegylated interferon alpha 2a plus ribavirin and mycophenolate in the management of patients with refractory chronic HCV infection
Scientific title
Acronym N/A
Serial number at source N0060110647
Study hypothesis In treating chronic HCV patients who failed to respond to standard interferon X, is the combination of PEG interferon plus ribervirin plus mycophenolate better than PEG plus ribavirin?
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Infections and Infestations: Hepatitis C
Participants - inclusion criteria 60 patients in each arm - 15-25 from C&W.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/04/2002
Anticipated end date 01/04/2004
Status of trial Completed
Patient information material
Target number of participants 60
Interventions Randomised, prospective trial.
Primary outcome measure(s) Sustained response 24-28 weeks post completion of therapy.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Chelsea and Westminster Healthcare NHS Trust
Trial website
Publications
Contact name Dr  David  Westaby
  Address Gastroenterology Dept
4th Floor, Management 3
Chelsea and Westminster Hospital
369 Fulham Road
  City/town London
  Zip/Postcode SW10 9NH
  Country United Kingdom
  Tel +44 (0) 20 8746 1076
  Fax x8100
  Email karen.hawkins@chelwest.nhs.uk
Sponsor Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2004
Last edited 21/11/2005
Date ISRCTN assigned 30/09/2004
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central